Vitamin B5 (Pantothenic Acid): The Hidden Engine Behind Adrenal Support

Author’s Clinical Note: Often ignored because ‘it’s in everything,’ Pantothenic Acid is the unglamorous backbone of Coenzyme A. If you suffer from chronic adrenal fatigue or sluggish lipid metabolism, sub-clinical B5 depletion is one of the first vectors I assess.

Vitamin B5 ( Pantothenic Acid ) is an essential, water-soluble micro-nutrient and the mandatory metabolic precursor for the synthesis of Coenzyme A (CoA) and the 4’-phosphopantetheine prosthetic group of the Acyl Carrier Protein (ACP). As the structural foundation of CoA, it facilitates the activation and transfer of acyl groups, placing it at the absolute center of carbohydrate, lipid, and protein catabolism. Pantothenic acid is the primary determinant of the body’s capacity for mitochondrial energy production, steroid hormone biosynthesis, and the post-translational modification (acetylation) of proteins.

VITAMIN B5: COENZYME A KINETICS & STEROIDOGENIC INTEGRATION

graph TD classDef title fill:#1a237e,stroke:#0d47a1,stroke-width:2px,color:#ffffff,font-weight:bold,font-size:16px classDef primary fill:#E3F2FD,stroke:#2196F3,stroke-width:2px,color:#0D47A1 classDef secondary fill:#F1F8E9,stroke:#4CAF50,stroke-width:2px,color:#1B5E20 classDef alert fill:#FFEBEE,stroke:#F44336,stroke-width:2px,color:#B71C1C classDef outcome fill:#E8F5E9,stroke:#2E7D32,stroke-width:2px,color:#1B5E20 Root["[INTENT] Pantothenate-Derived CoA Biosynthesis and Steroid Kinetics"]:::title Root --> CoA["ACETYL-GROUP KINETICS
Coenzyme A (CoA) Biosynthesis"]:::primary Root --> Adrenal["STEROIDOGENESIS
Adrenal Endocrine Regulation"]:::secondary subgraph Bioenergetic_Transformation_Centers ["Mitochondrial Bioenergetic Flux"] CoA -->|Catalyze| Krebs["TCA Cycle Carbon Assimilation"]:::primary CoA -->|Prosthetic| ACP["Acyl Carrier Protein Functionality"]:::primary CoA -->|Biosynthesis| Heme["Heme & Globin Porphyrinogenesis"]:::primary Krebs --> ATP["ATP Production Velocity (OxPhos)"]:::primary end subgraph Adrenal_Endocrine_Interface ["Endocrine Regulatory Kinetics"] Adrenal -->|Substrate| Cortisol["HPA Axis Steroidogenesis Pathway"]:::secondary Adrenal -->|Synthesis| Steroid["Corticosteroid & Androgen Flux"]:::secondary Cortisol --> Resilience["Physiological Stress Adaptation Threshold"]:::secondary end subgraph System_Flow ["Physiological Homeostasis"] ATP --- Link["Metabolic Homeostatic Threshold"]:::alert Resilience --- Link end Link --> Outcome["OPTIMAL COA SYNTHESIS AND STEROIDOGENIC FLUX"]:::outcome

Top Botanical and Animal Sources

xychart-beta title "Vitamin B5 (Pantothenic Acid): Top Food Sources (%DV/100g)" x-axis ["1", "2", "3", "4", "5", "6", "7", "8", "9", "10"] y-axis "%DV/100g" 0 --> 35 bar [31.6, 28, 24, 22, 19, 16.8, 15.7, 13.5, 13, 12.2]
RankFood (USDA FoodData Central)%DV per 100gAmount
1Chicken, broiler or fryers, breast, skinless, boneless, meat only, cooked, braised31.6%1.58 mg
2Turkey, ground, 93% lean, 7% fat, pan-broiled crumbles28%1.4 mg
3Sausage, pork, chorizo, link or ground, cooked, pan-fried24%1.2 mg
4Chicken, broilers or fryers, drumstick, meat only, cooked, braised22%1.1 mg
5Sausage, turkey, breakfast links, mild, raw19%0.952 mg
6Seeds, sunflower seed kernels, dry roasted, with salt added16.8%0.84 mg
7Sausage, Italian, pork, mild, cooked, pan-fried15.7%0.783 mg
8Cheese, ricotta, whole milk13.5%0.673 mg
9Bread, whole-wheat, commercially prepared13%0.65 mg
10Broccoli, raw12.2%0.61 mg
Data sources: USDA FoodData Central Foundation Foods (Dec 2025) and FDA Daily Values .

Healthcare Provider Summary

TopicKey data
Primary biomarkersUrinary pantothenic acid is used in research; no routine clinical test is standard.
Deficiency patternRare; fatigue, irritability, paresthesias, and “burning feet” can appear in severe deficiency.
Excess/toxicityHigh supplemental intakes may cause diarrhea or gastrointestinal upset.
Drug and nutrient interactionsShares intestinal transport with biotin; extremely high doses of one can reduce uptake of the other.
Higher-risk groupsSevere malnutrition, alcoholism, and long-term parenteral nutrition without adequate pantothenate.

Physiological Context

Pantothenic acid is required to synthesize coenzyme A and acyl-carrier proteins, supporting fatty acid metabolism and steroid hormone synthesis. Because it is widely distributed in foods, deficiency is uncommon.

Summary of Literature

Clinical use is mainly to correct deficiency or support nutrition in settings such as TPN. Evidence for high-dose supplementation beyond adequacy is limited.

1. Mitochondrial Bioenergetics: CoA Biosynthetic Pathway

The metabolic activation of pantothenic acid is governed by the enzyme Pantothenate Kinase (PANK), which serves as the rate-limiting step in the five-stage biosynthesis of Coenzyme A. Historically, isolated in 1933 by Roger Williams, pantothenic acid (from the Greek pantos, meaning “everywhere”) was identified as a mandatory growth factor for biological systems.

  • The Citric Acid Cycle: As Acetyl-CoA, it provides the primary carbon fuel for the TCA cycle, enabling the production of NADH and FADH₂ for ATP synthesis.
  • Fatty Acid Dynamics: CoA and the Acyl Carrier Protein (ACP) are required for the multi-enzyme Fatty Acid Synthase (FAS) complex, regulating the synthesis and elongation of long-chain fatty acids.
  • Neurotransmitter & Heme Synthesis: B5-derived CoA is the mandatory acetyl donor for the synthesis of acetylcholine and provides the succinyl-CoA units required for the initiation of heme biosynthesis.

3. Ubiquity and Bioavailability: The “Pantos” Paradigm

While pantothenic acid is ubiquitous in intact dietary sources, industrial processing often diminishes nutrient density. Relying on ultra-refined grains may lead to sub-clinical debt. Although overt deficiency is rare, latent insufficiency can manifest as persistent fatigue and reduced hypothalamic-pituitary-adrenal (HPA) axis responsiveness to physiological stressors.

2. Endocrine Homeostasis: Steroidogenesis and CoA

In human physiology, Vitamin B5 is the primary substrate governing the synthesis of the body’s entire steroid hormone milieu.

  • Cholesterol Biosynthesis: Acetyl-CoA units derived from B5 are required for the HMG-CoA reductase pathway, the critical rate-limiting step for cholesterol synthesis.
  • HPA Axis Integrity: Adequate cytosolic CoA pools in the adrenal cortex are mandatory for the transformation of cholesterol into cortisol, aldosterone, and DHEA, governing systemic homeostasis and stress adaptation.

3. Absorption and Metabolism: SMVT-Mediated Transport

Vitamin B5 is absorbed in the jejunum via the ‘ Sodium -Dependent Multivitamin Transporter’ (SMVT).

  • Competitive Transport Inhibition: Pantothenic acid shares this transporter with biotin (B7) and alpha-lipoic acid. High-dose administration of any single ligand can competitively inhibit the uptake of the others.
  • Erythropoietic Support: B5 is critical for heme biosynthesis, serving as a mandatory co-factor for the initiation of hemoglobin production within the bone marrow.

Clinical Metric: Adrenal Sequestration Kinetics

The adrenal glands maintain some of the highest tissue concentrations of pantothenic acid in the human body. Every steroidogenic pathway within the adrenal cortex is quantitatively dependent on available Coenzyme A for enzymatic catalysis.

Vitamin B5 Kinetics: Adrenal Dependency Index

graph TD classDef title fill:#1a237e,stroke:#0d47a1,stroke-width:2px,color:#ffffff,font-weight:bold classDef peak fill:#E3F2FD,stroke:#2196F3,stroke-width:2px,color:#0D47A1 classDef high fill:#E8F5E9,stroke:#43A047,stroke-width:2px,color:#1B5E20 classDef med fill:#FFF3E0,stroke:#E65100,stroke-width:2px,color:#BF360C classDef low fill:#FFEBEE,stroke:#F44336,stroke-width:2px,color:#B71C1C classDef result fill:#FAFAFA,stroke:#9E9E9E,stroke-width:2px,color:#212121 Root["[KINETICS] Core Adrenal Synthesis Volume %"]:::title Root --> P1["Cortisol Recovery (40%)"]:::peak Root --> P2["Aldosterone Hydration (30%)"]:::high Root --> P3["DHEA / Androgen Hub (30%)"]:::med subgraph Logic ["Adrenal Enzyme Flux"] P1 --- S1["Acetyl-CoA Pool Activation"]:::peak P2 --- S2["Osmotic Kinetic Balance"]:::high P3 --- S3["Steroidogenesis Kinetics"]:::med end S1 --> Final["OPTIMAL HORMONE BALANCE"]:::result S2 --> Final S3 --> Final

6. Bioavailability & Retention Kinetics

Pantothenic acid exhibits moderate thermal stability but is highly susceptible to leaching and degradation at industrial pH extremes.

  • Culinary Retention: Searing or light roasting preserves significantly more CoA-precursor potency than prolonged immersion boiling.
  • Bio-Activation: The consumption of whole-food sources like Persea americana (avocado) and ruminant liver provides the highest concentration of bioavailable pantothenate.

4. Ubiquity and Bioavailability: The “Pantos” Paradigm

While pantothenic acid is ubiquitous in intact dietary sources, industrial processing often diminishes nutrient density. Relying on ultra-refined grains may lead to sub-clinical debt. Although overt deficiency is rare, latent insufficiency can manifest as persistent fatigue and reduced hypothalamic-pituitary-adrenal (HPA) axis responsiveness to physiological stressors.

5. Clinical Dermatology: Sebum Regulation

High-dose pantothenic acid (utilizing doses significantly above the RDA) has been investigated for its ability to normalize sebum production in acne-prone individuals. This effect is hypothesized to be mediated by the enhanced β-oxidation of fatty acids, reducing the lipid load on the pilosebaceous unit.

6. Bioavailability & Retention Kinetics

Pantothenic acid exhibits moderate thermal stability but is highly susceptible to aqueous leaching and degradation at industrial pH extremes.

  • Culinary Retention: Searing or light roasting preserves significantly more CoA-precursor potency than prolonged immersion boiling.
  • Bio-Activation Profile: The consumption of whole-food sources like avocado and ruminant liver provides the highest concentration of bioavailable pantothenate.

7. Pharmacology of Pantothenate Derivatives

Calcium pantothenate is the standard supplemental form. However, Pantethine (the disulfide derivative of pantothenic acid) is often considered pharmacokinetically superior for therapeutic applications targeting lipid profiles. Pantethine has demonstrated clinical efficacy in reducing triglyceride levels and enhancing Coenzyme A production compared to standard pantothenic acid.

8. Drug-Nutrient Interactions

Certain medications can influence the B5 metabolic cycle. High-dose B5 may interact with cholinesterase inhibitors (Alzheimer’s medications) by potentially increasing their cholinergic side effects.

9. RDA and Precision Nutrition

The RDA for B5 is approximately 5mg. However, precision nutrition suggests that for specific therapeutic applications, such as sebum modulation (500mg - 2000mg/day), doses significantly above the RDA may be utilized under clinical supervision.

Professional Clinical Inquiries

Q: What is the biochemical etiology of “Burning Feet Syndrome”? A: Severe pantothenic acid deficiency impairs CoA-dependent lipid synthesis in the myelin sheath and reduces acetylcholine biosynthesis. This results in progressive peripheral neuropathy and autonomic dysfunction, manifesting clinically as distal paresthesia and painful thermo-sensitivity in the lower extremities.

Q: How does Pantothenate Kinase (PANK) regulate CoA production? A: PANK is the primary rate-limiting enzyme in the CoA biosynthetic pathway. It is regulated by feedback inhibition; high intracellular concentrations of CoA inhibit PANK activity, ensuring tissue-specific metabolic homeostasis and preventing co-factor imbalance.

Q: Why are the adrenal glands particularly sensitive to pantothenate status? A: The adrenal cortex maintains some of the highest physiological concentrations of Vitamin B5 to support the intense demand for Acetyl-CoA during the synthesis of cortisol, aldosterone, and DHEA. Sub-clinical deficit manifests as an impaired capacity for steroidogenesis during acute physiological or metabolic stress.

Q: Does competitive inhibition occur with high-dose biotin? A: Pantothenic acid and biotin (and alpha-lipoic acid) share the Sodium -Dependent Multivitamin Transporter (SMVT) for intestinal uptake. Pharmacological doses of one ligand (e.g., >5,000 mcg of biotin) can competitively inhibit the absorption of the other, necessitating staggered dosing in high-performance protocols.

Q: What defines the therapeutic utility of Pantethine? A: Pantethine, the disulfide derivative of B5, bypasses several enzymatic steps in the CoA pathway. It has demonstrated superior pharmacokinetic potential for modulating lipid profiles, specifically reducing triglycerides and enhancing CoA-mediated $\beta$-oxidation efficiency compared to standard calcium pantothenate.

Q: Can B5 influence sebum regulation and acne? A: High-dose pantothenic acid may normalize sebum production by increasing the rate of fatty acid $\beta$-oxidation. By enhancing the utilization of intracellular lipids for energy, B5 reduces the substrate availability for sebocyte lipid synthesis, mitigating follicular inflammation.

Source CategoryTop ExamplesBioavailability ScoreNutrient Focus
Animal-BasedBeef Liver, Egg Yolks, Chicken95%Direct CoA Support
Plant-BasedAvocado, Sunflower Seeds, Lentils85%Steroidogenic Support
Tech-BasedPantethine (Activated B5)99%Precision Metabolic Boost

Complete Biochemical Profile: Pantothenic Acid

To optimize systemic metabolic integration, it is critical to understand that Pantothenic Acid operates not in isolation, but as a systemic regulatory node. Below is the advanced clinical profile mapping its direct physiological impact vectors.

Core Biological Functions

  • Acyl Group Transfer: Mandatory co-factor (as CoA) for the catabolism of all macronutrients.
  • Lipid Biosynthesis: Essential substrate for the synthesis of cholesterol, fatty acids, and sphingolipids.
  • Post-Translational Acetylation: Provides the acetyl groups required for histone and tubulin acetylation, modulating genomic expression and cellular structure.

Early-Stage Depletion Signs

Sub-clinical pantothenate debt often manifests as impaired stress tolerance, persistent fatigue, and neuro-muscular irritability. Because B5 is ubiquitous in the food supply, severe deficiency is rare but manifests pathologically as “Burning Feet Syndrome” (paresthesia), accompanied by gastrointestinal distress and impaired insulin sensitivity. Chronic sub-saturation is a primary driver of adrenal insufficiency and compromised epidermal barrier function. NIH ODS

Unlike acute disease, sub-clinical deficiency manifests as a “slow biological leak”—a chronic feeling of fatigue, brain fog, and poor recovery from exercise. Because standard blood tests often measure extracellular limits rather than intracellular saturation, millions walk around functionally deficient.

VITAMIN B5: THE CLINICAL DEFICIENCY SPECTRUM

graph TD classDef title fill:#1a237e,stroke:#0d47a1,stroke-width:2px,color:#ffffff,font-weight:bold,font-size:16px classDef optimal fill:#E3F2FD,stroke:#2196F3,stroke-width:2px,color:#0D47A1 classDef subclinical fill:#FFF3E0,stroke:#E65100,stroke-width:2px,color:#BF360C classDef clinical fill:#FFEBEE,stroke:#F44336,stroke-width:2px,color:#B71C1C classDef result fill:#FAFAFA,stroke:#9E9E9E,stroke-width:2px,color:#212121 Root["[STATUS] Systemic CoA Saturation"]:::title Root --> Stage1["Stage 1: Optimal Resiliency"]:::optimal Root --> Stage3["Stage 3: Clinical Collapse"]:::clinical Stage1 --> Stage2["Stage 2: Sub-Clinical Debt"]:::subclinical Stage2 --> Stage3 subgraph Status_1 ["Optimal"] Stage1 --- OptNotes["Full CoA Reservoirs / Peak Adrenal Recovery"]:::optimal end subgraph Status_2 ["Sub-Clinical"] Stage2 --- SubNotes["Latent HPA Axis Insufficiency / Recovery Delay"]:::subclinical end subgraph Status_3 ["Clinical"] Stage3 --- ClinNotes["Distal Paresthesia / Global Metabolic Shutdown"]:::clinical end Stage1 --> Finish["Metabolic Resilience"]:::result Stage3 --> Finish

Obligate Biological Partners

Biological systems are interdependent. Consuming isolated Pantothenic Acid without its required synergistic partners can actually induce relative deficiencies elsewhere in the body’s matrix.

  • Primary Co-Factor: Vitamin C . You must secure adequate intake of this co-factor to ‘unlock’ the absorption and utilization of Pantothenic Acid .
  • Lipid vs. Water Solubility: Depending on the exact molecular form ingested, Pantothenic Acid often requires the presence of high-quality dietary fats to cross the intestinal wall efficiently.

Q: Why is Vitamin C considered a crucial synergist for Pantothenate? A: Both nutrients are highly concentrated in the adrenal glands and are mandatory for the synthesis of stress hormones. Vitamin C protects the adrenal cortex from oxidative damage generated during intense steroidogenesis, while B5 provides the requisite Coenzyme A for hormone biosynthesis.

Q: How does B5 status impact neurotransmission? A: Acetyl-CoA is the mandatory acetyl donor for the enzyme choline acetyltransferase, which synthesizes the neurotransmitter acetylcholine. B5 status is thus a primary determinant of cholinergic signaling velocity and autonomic nervous system stability.

Precision Medicine & Advanced Lab Testing

Pharmacological Interactions: Oral contraceptives and systemic estrogen replacement therapies significantly accelerate the metabolic clearance of Pantothenic Acid, elevating baseline requirements beyond standard RDAs.

Genomic Modifiers: The PANK2 gene (Pantothenate Kinase 2) controls the very first step in assembling Coenzyme A from B5. Rare mutations here trigger severe neurodegeneration (PKAN), highlighting B5’s critical neural dependency.

Advanced Assessment: Because B5 is ubiquitous, serum levels indicate only recent dietary intake. Whole-blood Pantothenic Acid or 24-hour urinary excretion represents the only reliable metric for longitudinal status.

Advanced Clinical Expansion

Intestinal Absorption Kinetics

Pantothenic acid is absorbed in the small intestine through the sodium-dependent multivitamin transporter (SMVT) and is rapidly converted to coenzyme A.

VITAMIN B5: METABOLIC FLOW & KINETICS

graph TD classDef title fill:#1a237e,stroke:#0d47a1,stroke-width:2px,color:#ffffff,font-weight:bold,font-size:16px classDef primary fill:#E3F2FD,stroke:#2196F3,stroke-width:2px,color:#0D47A1 classDef secondary fill:#F1F8E9,stroke:#4CAF50,stroke-width:2px,color:#1B5E20 classDef alert fill:#FFEBEE,stroke:#F44336,stroke-width:2px,color:#B71C1C Root["[LOGISTICS] Pantothenate Homeostasis"]:::title Root --> In["[ENTRY] Bio-Input Flux"]:::primary In --> Hub["Small Intestine / Jejunum Interface"]:::primary subgraph Absorption ["Distribution Partition"] Hub -->|Priority| SMVT["SMVT Sodium Transporter Flux"]:::primary Hub -->|Inhibition| Biotin["Biotin / Lipoic Competition"]:::alert SMVT --> RBC["Red Blood Cell Carrier Pool"]:::secondary end subgraph Processing ["Intracellular Sequestration"] RBC -->|Synthesis| CoA["Hepatic CoA Biosynthesis Matrix"]:::secondary RBC -->|Hormone| Adrenal["Adrenal Cortical Sequestration"]:::secondary end subgraph usage ["Excretion Dynamics"] CoA --> Out["[EXIT] Renal Metabolite Clearance Flux"]:::alert end RBC --> Final["SYSTEMIC PHYSIOLOGICAL STABILITY"]:::secondary

Body stores are small because this vitamin is widely distributed and constantly used in acetyl-CoA reactions. Excess is excreted in urine. Consistent daily intake is more important than large sporadic doses.

Co-Factor Interaction Mapping

  • Pantothenic acid shares the SMVT transporter with biotin and lipoic acid, so very high doses can compete.
  • It is central to acetyl-CoA production, linking carbohydrate, fat, and protein metabolism.
  • Adequate B6 supports downstream acetylation and neurotransmitter synthesis pathways.

Dietary Matrix Considerations

Pantothenic acid is widely distributed in foods, but processing, canning, and refining reduce content.

VITAMIN B5: CULINARY MATRIX & SYNERGY

graph TD classDef title fill:#1a237e,stroke:#0d47a1,stroke-width:2px,color:#ffffff,font-weight:bold,font-size:16px classDef primary fill:#E3F2FD,stroke:#2196F3,stroke-width:2px,color:#0D47A1 classDef secondary fill:#F1F8E9,stroke:#4CAF50,stroke-width:2px,color:#1B5E20 classDef alert fill:#FFEBEE,stroke:#F44336,stroke-width:2px,color:#B71C1C Root["[CULINARY] Bio-Optimization Matrix"]:::title Root --> In["Source Density Profile"]:::primary Root --> Mod["Bio-Synergy Factors"]:::secondary subgraph Matrix ["Food Source Sequestration"] In --> S1["[Peak] Beef Liver / Organ Meats"]:::primary In --> S2["[Active] Avocado / Whole Seeds"]:::primary In --> S3["[Support] Legumes / Lentils"]:::primary end subgraph Optimization ["Bioavailability Optimization"] Mod -->|Co-Factor| Boot1["Vitamin C (Adrenal Protection)"]:::secondary Mod -->|Partner| Boot2["B-Complex Homeostasis"]:::secondary Mod -->|Degradation| Block1["Aqueous Leaching (Cooking Media)"]:::alert Mod -->|Attrition| Block2["Industrial Refining / Milling"]:::alert end Matrix --> Bottom["MAXIMUM COA BIO-SYNTHESIS"]:::secondary Optimization --> Bottom

Gentle cooking preserves more than high-heat, long-duration methods. Whole-food variety is the best protection against low intake.

Exogenous Supplement Vectors

FormWhat it isBest-fit use caseCautions
Calcium pantothenateStandard supplemental formGeneral repletion and maintenanceLarge doses may cause GI upset
PantethineActive derivative used in some lipid protocolsTargeted metabolic supportNot necessary for routine use
Food-based blendsYeast or food concentratesGentle daily supportVariable potency

Identifying Clinical Signatures

StageWhat shows upNotes
Early low statusFatigue, irritability, low stress toleranceOften masked by other deficiencies
Progressed deficiencyParesthesias, "burning feet", sleep disruptionRare, usually severe malnutrition
Excess intakeDiarrhea or mild GI distressUsually resolves with lower dose

Specific Contexts and Conditions

  • Severe malnutrition, alcoholism, and dialysis increase risk of low status.
  • High-stress periods can increase perceived need because of steroid hormone synthesis.
  • People with very restricted diets benefit from broad food diversity.

Disclaimer: This guide is for educational purposes. Coordinate your adrenal support and lipid metabolism protocols with your primary physician or endocrinologist. NIH ODS

About the Scientific Authors & Fact-Checking

This clinical guide was meticulously researched and fact-checked by Vasyl Haborets and Natalia Haborets. As scientific researchers specializing in molecular nutrition, their work is exclusively based on peer-reviewed biomedical literature and primary data strictly sourced from the NIH Office of Dietary Supplements.

FDA & Medical Disclaimer: The statements regarding dietary supplements on this page have not been evaluated by the Food and Drug Administration. The information provided is highly technical and is not intended to diagnose, treat, cure, or prevent any disease. All clinical data is presented for educational purposes only. Always consult a licensed healthcare professional before altering your nutritional intake or starting supplementation.

Methodology & Primary Data Sources: Consensus intake targets, safety limits, and structural food data matrices across this platform are reliably derived from the NIH Office of Dietary Supplements (ODS) and the USDA FoodData Central. Evidence maps represent mechanistic pathways for educational orientation and should not replace primary clinician diagnostics.